Health ministry decides against including Itolizumab in clinical management protocols for COVID-19
The permission to market the drug was granted for the treatment of cytokine release syndrome in 'moderate' to 'severe' Acute Respiratory Distress Syndrome patients due to COVID-19. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 25, 2020 Category: Pharmaceuticals Source Type: news

Innovations can help India's biotechnology economy to hit USD 100 billion by 2025: Amitabh Kant
Addressing a webinar titled 'Global Perspective on India's Biotech Potential: Manufacturing Hub& Foreign Investment', Kant said India is working to boost the biotechnology sector under the flagship programmes like 'Make in India' and 'Startup India'. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2020 Category: Pharmaceuticals Source Type: news

Sun Pharma's arm Taro resolves all cases with United States Department of Justice
Under a deferred prosecution agreement reached with the DOJ, it said, adding that the dept will file an information for conduct that took place between 2013 and 2015. Taro Pharmaceutical said, if the company adheres to the terms of the agreement, including the payment of USD 205.7 million, the DOJ will dismiss the information at the end of a 3-year period. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2020 Category: Pharmaceuticals Source Type: news

Mumbai-based Vishat Diagnostics gets ICMR nod to supply COVID-19 antigen testing kit
"With COVID-19 Ag Respi-Strip, we are bringing CE certified and ICMR approved kits at affordable prices, which is also our company's driving force for all other product lines," Vishat Diagnostics MD Pratik Chaitala said. At a time when India is touching its peak in daily numbers of cases, it becomes critical to rapidly increase testing, he added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2020 Category: Pharmaceuticals Source Type: news

Chemists procure over 1000 vials of Remdesivir to fight Covid-19 crisis in Kashmir
The administration maintains that the health infrastructure in Valley is equipped enough to deal with the crisis, however, the scenes at the hospitals and complaints of patients belie the official claims. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 22, 2020 Category: Pharmaceuticals Source Type: news

Cipla all set to launch Favipiravir drug for treatment of COVID patients: CSIR
An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatment of COVID-19 patients, especially in mild and moderate cases. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 22, 2020 Category: Pharmaceuticals Source Type: news

Piyush Goyal calls for removing hurdles in access to medicines at affordable prices
"The minister called for removing multiple hurdles in access to medicines at affordable prices created by the lopsided WTO rules for protecting intellectual property," a ministry statement said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 22, 2020 Category: Pharmaceuticals Source Type: news

Trial results show significant faster time to clinical improvement with Favipiravir: Glenmark
Results from the Phase 3 trial showed numerical improvements for the primary efficacy endpoint with 28.6 per cent faster viral clearance in the overall population in the Favipiravir plus standard supportive care compared to those in the standard supportive care alone (control arm) , Glenmark said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2020 Category: Pharmaceuticals Source Type: news

Piramal Critical Care partners with Medivant Healthcare to supply injectable drugs in US
Piramal Critical Care on Wednesday said it has partnered with US-based pharmaceutical outsourcing facility Medivant Healthcare to address severe shortage of injectable drugs in hospitals across the United States. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2020 Category: Pharmaceuticals Source Type: news

Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat
Drug firm Unichem Laboratories on Wednesday said it has received approval from the US health regulator for its Amiodarone tablets used to treat irregular heartbeat. The approved product is a generic version of Wyeth Pharmaceuticals Inc's Cordarone tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2020 Category: Pharmaceuticals Source Type: news

Mylan gets DCGI nod for anti-tuberculosis drug Pretomanid for conditional access
The Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Program (NTEP), Mylan said in a statement. Through the conditional access approval from DCGI, Mylan will initially make its Pretomanid available in India through a donation of 400 treatment courses to the NTEP, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2020 Category: Pharmaceuticals Source Type: news

Covid-19 vaccine by October-November: Adar Poonawala to Odisha CM Naveen Patnaik
Serum Institute of India CEO Adar Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2020 Category: Pharmaceuticals Source Type: news

Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice
“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” the company said in a statement. The company said that Favipiravir in India when launched was at the lowest market cost (Rs 103/tab) as compared to its cost in other countries where it was approved like Russia, Japan, Bangladesh and China. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2020 Category: Pharmaceuticals Source Type: news

Possible but not certain COVID-19 vaccine rolled out this year: Oxford developer
"The end of the year target for getting vaccine rollout, it's a possibility but there's absolutely no certainty about that because we need three things to happen," said Sarah Gilbert, adding it needed to be shown to work in late stage trials, there needed to be large quantities manufactured and regulators had to agree quickly to licence it for emergency use. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2020 Category: Pharmaceuticals Source Type: news

Biocon partners with Voluntis to develop digital therapeutics for diabetes patients
The licensing agreement, signed between Biocon Biologics ’ subsidiary Biocon Sdn. Bhd., Malaysia and Voluntis, would make Biocon Biologics one of the first insulin companies to offer a US Food and Drug Administration-cleared and CE-marked, digital therapeutic product - Insulia - to Type 2 diabetes patients, said Biocon in a press release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2020 Category: Pharmaceuticals Source Type: news

Novartis turning to technology to manage business: Bertrand Bodson, Chief Digital Officer
Swiss drugmaker Novartis is turning to tech to deal with the pharma business in times of pandemic, as companies go virtual. Bertrand Bodson, chief digital officer, Novartis, in an interview shares how the company is innovating its business in the time of pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2020 Category: Pharmaceuticals Source Type: news

Airborne transmission of Covid possible, wear masks in enclosed spaces, cautions CSIR
Amid recent acknowledgement from the World Health Organisation (WHO) over emerging evidence of airborne spread of the novel coronavirus, the head of India ’s premier R&D body has said that airborne transmission of SARS-CoV-2 is indeed a “distinct possibility” and suggested wearing masks even in “enclosed” spaces. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2020 Category: Pharmaceuticals Source Type: news

AstraZeneca vaccine's success in early human trials bodes well for Adar Poonawalla and Serum Institute
Adar Poonawalla's Serum Institute of India is one of Astra Zeneca's partners in the search for the vaccine and will potentially be responsible for the mass manufacture of the final product. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Coronavirus cure: Human clinical trials for Covaxin begins at NIMS in Hyderabad
The company has developed the vaccine in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Serum Institute of India to apply for local trials on Oxford's vaccine by August
SII, the largest vaccine manufacturer in the world, has tied up with AstraZeneca to manufacture the Covid-19 vaccine. SII ’s vaccine candidate is undergoing a bio safety trial at the government's Central Drug Laboratory (CDL), Kasauli. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Cipla settles case with Amgen Inc involving generic cinacalcet hydrochloride tablets
A formal stipulation of dismissal has been filed with the court and is awaiting signature by the presiding Judge, the filing added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets tentative nod from USFDA for type-2 diabetes management drug
Alembic Pharma said it is currently in litigation with Boehringer Ingelheim in District Court of Delaware and launch of the product will depend on litigation outcome. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Mylan launches remdesivir in India under the brand name DESREM for Covid-19 treatment
The drug is approved for the treatment of suspected or laboratory confirmed incidences of Covid-19 in adults and children hospitalised with severe infection. The company also launched a helpline where patients and healthcare practitioners can access information about Mylan ’s Remdesivir and its availability. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Over 158 applications for generic products pending with USFDA for approval: Lupin
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last fiscal and saw an increase of 5 per cent on the back of products like Levothyroxine and Oseltamivir. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Draw up immunisation strategy now itself for COVID-19 vaccine: Kiran Mazumdar-Shaw
"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by the end of the year", Mazumdar-Shaw said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Public and private sectors tie up to deal with mental stress during the pandemic
VIMHANS, a multi-specialty institute providing comprehensive care in the fields of Mental Illnesses and Neuro Sciences is also considering to offer pro bono services during the pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Oxford coronavirus vaccine prompts immune response in early test
Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2020 Category: Pharmaceuticals Source Type: news

Aim to gain market share, protect supply chain, preserve cash amid COVID-19 uncertainties: Sun Pharma
"Our endeavour will be to gain market share in each of our business by doing better. Despite the near-term uncertainties related to COVID-19, we hope to be able to do better consistently," Sun Pharmaceutical Industries MD Dilip Shanghvi said in an analyst call. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 18, 2020 Category: Pharmaceuticals Source Type: news

Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India. Vaccines normally require years of testing and additional time to produce at scale, but scientists are hoping to develop a vaccine within months. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 18, 2020 Category: Pharmaceuticals Source Type: news

DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFlu
Drug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 18, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets final approval from USFDA to market generic tension headache tablets
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tablets in strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement. The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis in the US, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 17, 2020 Category: Pharmaceuticals Source Type: news

Panel recommends renaming India's drug regulator for better international visibility
A high-level committee has proposed three options — Central Medical Products Administration, India (CMPA), Central Medical Products Regulatory Agency, India (CMPRA), and National Medical Products Regulatory Agency, India (NMPRA) — to rename the agency. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 17, 2020 Category: Pharmaceuticals Source Type: news

Bharat Biotech starts human trial of its anti-COVID vaccine at PGI Rohtak: Minister Vij
“Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today,” Vij, who is also the Home and Science& Technology minister said. “Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects,” Vij further said in his tweet. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 16, 2020 Category: Pharmaceuticals Source Type: news

The Novavax story: How a struggling company won $1.6 billion to make a coronavirus vaccine
Although the company, based in Gaithersburg, Maryland, had never brought a vaccine to market in its 33-year history, these experts were optimistic about its technology, which uses moth cells to pump out crucial molecules at a much faster rate than typical vaccines — a major advantage in a pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 16, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets nod from Mexican authority for clinical trials of COVID-19 therapy
In a regulatory filing, Zydus Cadila said it had received approval from the Mexican regulatory authority Cofepris to conduct clinical trials with its biological therapy, Pegylated Interferon alpha-2b, 'PegiHepTM'. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 16, 2020 Category: Pharmaceuticals Source Type: news

Japan ’s hygiene major Saraya picks up majority stake in Mystair Hygiene
Saraya, based in Osaka, is a leading global manufacturer of infection control, sanitation and hygiene products with 12 factories, 3 R&D labs. Saraya ’s line of business extends from hand hygiene products to all forms of sanitation such as food safety, infection prevention and control, and public health, as well as functional foods. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 16, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila aims to complete trial of coronavirus vaccine by March: Chairman Pankaj Patel
Cadila's vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 16, 2020 Category: Pharmaceuticals Source Type: news

Indian pharma industry capable of producing COVID-19 vaccines for entire world: Bill Gates
Speaking in a documentary -- COVID-19: India's War Against The Virus -- to be premiered on Discovery Plus this (Thursday) evening, Gates said India also faces a huge challenge due to the health crisis because of its gigantic size and urban centres with a lot of population density. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for manufacturing Doxycycline Injection at Vadodara
Drug firm Zydus Cadila on Thursday said it has received approval from the US health regulator for manufacturing Doxycycline Injection at its Jarod facility, in Gujarat. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2020 Category: Pharmaceuticals Source Type: news

Human trials of COVID-19 vaccine candidate important milestone for Atmanirbhar Bharat: DBT
Zydus Cadila's move to begin human trials of its indigenously developed vaccine candidate for COVID-19 is an important milestone for an 'Atmanirbhar Bharat', Department of Biotechnology Secretary Renu Swarup said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2020 Category: Pharmaceuticals Source Type: news

India needs holistic ecosystem to rebuild API manufacturing facilities: PwC India
The study recommended that to revive the API industry, in the immediate term there is a need for faster environment clearance, encouraging manufacturing of key APIs/intermediates and fermentation products by providing a fiscal stimulus, accommodative pricing policy under the Drug Price Control Order, 2013 and financial incentives. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila begins human trials of its COVID-19 vaccine, aims for an early 2021 launch
The company said in the preclinical stage the vaccine was found to be safe, immunogenic and well-tolerated. It was also able to produce neutralising antibodies in animal studies, a key requirement for a vaccine. In the phase-I and II trials, the company will assess the safety, tolerability and immunogenicity of the vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 15, 2020 Category: Pharmaceuticals Source Type: news

Good news on Oxford, AstraZeneca's coronavirus vaccine could come on Thursday: Report
HEALTH-CORONAVIRUS-OXFORD-VACCINE-Positive news on Oxford/AstraZeneca COVID-19 vaccine could come Thursday: report (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2020 Category: Pharmaceuticals Source Type: news

TN to launch trial to study efficacy of BCG vaccine to reduce COVID-19 mortality for elders
This is significant as the study will see whether the vaccine ’s potential to combat Covid-19 and prevent hospitalisation among the aged as they are more susceptible to picking up the infection as they often suffer from co-morbid conditions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Moderna's Covid vaccine shows promise, to enter final stage of human trials this month
The study should run until October 27, 2022, but preliminary results should be available long before. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2020 Category: Pharmaceuticals Source Type: news

ETIG Analysis: Pharma companies involved in rolling out Covid-19 treatments face ESG implications
Moody's Investor Services said in a report last week that the ongoing Covid-19 vaccine development globally comes with both positives as well as negatives for pharma companies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila begins human clinical trials of COVID-19 vaccine candidate
Drug firm Zydus Cadila on Wednesday said it has started human clinical trials of its COVID-19 vaccine candidate ZyCoV-D. In the phase of trials, the company will be enrolling over 1,000 subjects across multiple clinical study sites in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Hetero starts supply of 60,000 vials of generic Remdesvir for treatment of Covid-19 patients
Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Covid-19 test kit Corosure developed by IIT Delhi launched; base price at Rs 399
With the launch, the RT-PCR based Covid-19 diagnostic kit will now be available for use by the authorised testing labs. Even after adding the RNA isolation and laboratory charges, the cost per test will be considerably cheaper compared to currently available kits in the market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Pharma major Cipla gets USFDA nod for rare genetic condition treatment drug
Cipla's Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire's Firazyr, the company said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 13, 2020 Category: Pharmaceuticals Source Type: news